For example, an employer might allow Wegovy with a $150 monthly copay under pharmacy benefits if the employee has a documented BMI35, but disallow it if BMI =35), documented lifestyle program participation, specialist prescribing, etc
39 GLP-1RA are currently used to treat obesity and diabetes, as well as other diseases such as cardiovascular and neurodegenerative diseases
This is absolutely true
Communication with your healthcare team is essential for long-term success
Aim the needle at the vial wall, not directly at the peptide powder
It is more useful to review current goals, current medications, adverse effects, glucose patterns, weight history, and cardiometabolic risk with a clinician